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Dynamic adaptations of one’s behavior bymeans of performancemonitoring are a central function of the human executive system, that
underlies considerable interindividual variation. Converging evidence from electrophysiological and neuroimaging studies in both
animals andhumans hints at the importance of the dopaminergic system for the regulation of performancemonitoring.Here, we studied
the impact of two polymorphisms affecting dopaminergic functioning in the prefrontal cortex [catechol-O-methyltransferase (COMT)
Val108/158Met and dopamine D4 receptor (DRD4) single-nucleotide polymorphism (SNP)-521] on neurophysiological correlates of
performance monitoring. We applied a modified version of a standard flanker task with an embedded stop-signal task to tap into the
different functions involved, particularly errormonitoring, conflict detection and inhibitory processes. Participants homozygous for the
DRD4 T allele produced an increased error-related negativity after both choice errors and failed inhibitions compared with
C-homozygotes. This was associated with pronounced compensatory behavior reflected in higher post-error slowing. No group differ-
ences were seen in the incompatibility N2, suggesting distinct effects of the DRD4 polymorphism on error monitoring processes. Addi-
tionally, participants homozygous for the COMTVal allele, with a thereby diminished prefrontal dopaminergic level, revealed increased
prefrontal processing related to inhibitory functions, reflected in the enhanced stop-signal-related components N2 and P3a. The results
extend previous findings frommainly behavioral and neuroimaging data on the relationship between dopaminergic genes and executive
functions and present possible underlying mechanisms for the previously suggested association between these dopaminergic polymor-
phisms and psychiatric disorders as schizophrenia or attention deficit hyperactivity disorder.
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Introduction
Performancemonitoring enables humans to adapt their behavior
and comprises error detection and correction, functions that are
instigated by the anterior cingulate cortex (ACC), inferior frontal
gyrus, dorsolateral prefrontal cortex (PFC), and insular cortex
(Carter et al., 1998; Gehring and Knight, 2000; Ullsperger and
von Cramon, 2001). Considerable interindividual variability in
performance monitoring raises the question for underlying dif-
ferences in neurotransmitter systems, particularly dopamine
functioning (Cohen et al., 2002; Seamans and Yang, 2004).
A role of dopamine in performance monitoring is suggested
by altered executive functions in diseases such as schizophrenia
and Parkinson’s disease (Falkenstein et al., 2001; Laurens et al.,
2003) and the rich dopaminergic innervation of aforementioned
prefrontal areas (Seamans andYang, 2004).Moreover, a previous
theory posits a central role of the mesencephalic dopaminergic
system in the generation of the error-related negativity (ERN), a
neurophysiological marker of action monitoring that is gener-
ated in the ACC (Holroyd and Coles, 2002).
Previous studies hint at genetic differences that may account
for interindividual variation in dopaminergic functioning and
thereby in performance monitoring (Fossella et al., 2002; Blasi et
al., 2005). One frequently studied single-nucleotide polymor-
phism (SNP) is located in the catechol-O-methyltransferase
(COMT) gene and refers to a G-to-A change at codon 158/108,
resulting in a Valine to Methionine substitution. COMT is a ma-
jor enzyme in dopamine degradation particularly in prefrontal
areas because of a lack of the dopamine transporter in this region
(Chen et al., 2004). The Methionine allele leads to a threefold to
fourfold reduction in COMT activity (Chen et al., 2004). This
polymorphism has been related to altered performance in tests
for executive functions and differences in both prefrontal brain
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activation (Egan et al., 2001) and PFC–midbrain interaction
(Akil et al., 2003; Meyer-Lindenberg et al., 2005).
The dopamine D4 receptor (DRD4) gene, which shows pref-
erential expression in the PFC (Oak et al., 2000), has been impli-
cated in prefrontal dysfunctions in schizophrenia and attention
deficit hyperactivity disorder (ADHD) (Okuyama et al., 1999;
Bellgrove et al., 2005a). The SNP -521 refers to a C-to-T substi-
tution, with the T allele resulting in 40% less transcriptional effi-
ciency (Okuyama et al., 1999; but see Kereszturi et al., 2006).
Here we investigated the combined impact of these two poly-
morphisms on neurophysiological correlates (event-related po-
tentials, ERPs) of performancemonitoring.We used a combined
flanker-stop-signal paradigm, which has been widely used to in-
vestigate error detection and correction (Gehring et al., 1993;
Rodriguez-Fornells et al., 2002) and inhibitory processes (Pliszka
et al., 2000; Liotti et al., 2005), andmoreover in behavioral studies
tapping into effects of dopaminergic polymorphisms (Fossella et
al., 2002). Because imaging studies demonstrated higher prefron-
tal activity related to attentional control in COMT Val homozy-
gotes (Blasi et al., 2005), we expected an enhancement of neuro-
physiological correlates of performance monitoring as the ERN
and N2, that emanate from the ACC and PFC. Previous results
regarding the DRD4 polymorphism are only tentative, but given
the suggested higher risk for schizophrenia in C homozygotes
(Okuyama et al., 1999) (but see Mitsuyasu et al., 2007), we hy-
pothesized rather diminished prefrontal functioning in this
group.
Materials andMethods
All procedures were approved by the local ethical Institutional Review
Board (IRB00003099).
Participants. The genotyping was performed in a large sample of 656
students from the University of Barcelona (491 women; age range from
18 to 56; mean, 21.7; SD, 3.5), who underwent a comprehensive neuro-
psychological test battery. We initially performed the genotyping for six
different polymorphisms in the dopaminergic system, namely COMT
Val108/158Met, DRD4–521, DRD4 120 bp, DRD4 exon III, monoamine
oxidase A (MAO-A) 30 bp, and dopamine transporter (DAT1) variable
number of tandem repeat polymorphism. The allele frequencies for the
different polymorphisms were as follows: COMT methionine, 45.7%;
DRD4–521 T allele, 52.9%; DRD4 120 bp 2-repeat, 78.5%. The DRD4
exon III allele frequencies were as follows: 8.7% (2 repeat), 2.7% (3
repeat), 70.9 (4 repeat), 1.5% (5 repeat), 0.3% (6 repeat), and 15.9% (7
repeat). TheMAO-A30bp allele frequencieswere 0.3% (2 repeat), 30.9%
(3 repeat), 1.8% (3.5 repeat), 65.9% (4 repeat)
and 1.2% (5 repeat). DAT1 allele frequencies
were 0.2% (8 repeat), 35.4% (9 repeat), 64.4%
(10 repeat) and 0.1% (11 repeat).
Genotype effects on parameters in the neu-
ropsychological test battery were most prom-
ising for the COMT and DRD4–521 poly-
morphisms (these results will be presented
elsewhere). We thus selected 53 (36 women;
age range, 18–34 years; mean, 21.2) partici-
pants based on their DRD4–521 and COMT
alleles for the ERP-session. All were right-
handed participants of European ancestry,
except one Peruvian-Spanish man, and were
free of neurological and psychiatric disorders
(self report). They were paid for their partic-
ipation and gave written informed consent.
We included only participants who were ho-
mozygous for both polymorphisms, yielding
a two-by-two factorial design with the four
groups T-Val, T-Met, C-Val, and C-Met. Two
participants had to be excluded because of a
genotyping error (TC-Met instead of TT-Met
and TC-Val instead of TT-Val) and one (T-Met) did not follow the
instructions (no inhibitions in stop trials) (see below). We thus had
10 participants in the T-Met group and excluded respectively partic-
ipants in the other groups based on their data quality (percentage of
artifact rejections) to have the same number of participants in each
group (n  10; in total n  40, 26 women; for the gender and age
distribution in each group) (Table 1). The allele frequencies in these
40 participants for the other genotyped polymorphisms were as fol-
lows: DRD4 exon III, 11.3% (2 repeat), 1.6% (3 repeat), 72.6% (4
repeat), 3.2% (5 repeat), 11.2% (7 repeat); DRD4 120 bp 2 repeat,
78.2%; DAT1, 35.9% (9 repeat), 64.1% (10 repeat); MAO-A 30 bp,
21.3% (3 repeat), 5% (3.5 repeat), 68.7% (4 repeat) and 5% (5 repeat).
The allele frequencies of the nonstudied polymorphisms are thus
comparable in the initial sample and the ERP sample.a It might be,
that the other genotyped polymorphisms also have an influence on
the processes under study, which we missed with the current selec-
tion. Obviously, the other genotyped polymorphisms as well as other
polymorphisms of the DRD4 and COMT gene (Barr, 2001; Diaz-
Asper et al., 2006), or other polymorphisms affecting dopamine or
other neurotransmitter systems might have an additional impact on
neural correlates of performance monitoring.
Genotyping. DNA contributed to the study was prepared by stan-
dard techniques from two independent EDTA blood samples of each
participant. Genotyping of the -521 C/T polymorphism in the DRD4
promoter (Okuyama et al., 1999) as well as the COMT G-to-A poly-
morphism at codon 108/158 (short/long isoform) resulting in valine
to methionine substitution (Lachman et al., 1996) was performed
using real-time fluorescence resonance energy transfer PCR. The re-
gion spanning the SNP was amplified with the primers DRD4 for (5
CTGAGGGCCAGAGGC TG 3)/DRD4rev (5GAGGAT CAA CTG
TGC AAC GG 3) and COMT for (5 GGG CCT ACT GTG GCT ACT
CA 3)/COMTrev (5 TTC AGT GAA CGT GGT GTG AAC A 3),
respectively. The polymorphic base nucleotide is covered by the flu-
orescein labeled donor probe (DRD4sensor 5 CGG GCG TGG AGG
GCG CG-Fl 3; COMTsensor 5 ATT TCG CTG GCA TGA AGG ACA
A-Fl 3). The adjacent acceptor probe (DRD4anchor 5 LCRed610-
GAC TCG CCT CGA CC-LCRed610-TCG T 3; COMT anchor 5
LCRed610- GTG TGC ATG CCT GAC CCG TTG TCA-ph 3) was
labeled with LCRed640 (Roche, Grenzach-Wyhlen, UK). Melting
curve analysis of the matrix-probe duplex is allele-dependent and
allows discrimination of the two SNP alleles. Primers and probes were
designed and synthesized by Tib Molbiol (Berlin, Germany). Ampli-
aParticipants for the ERP sessionwere selected randomly from the respective genotype groups in the initial sample,
without considering their individual performance in the neuropsychological test battery. They can be thus assumed
to be representative for the initial sample.
Table 1. Demographic, behavioral, and EEG data
C/Met C/Val T/Met T/Val
Sex (F/M) 6/4 7/3 6/4 7/3
Age (mean, years) 20.3 20.2 23.8 21.4
RT (compatible) 362.2 402.2 367.6 360.4
RT (incompatible) 391.6 424.8 394.4 385.9
RT difference 29.4 22.6 26.8 25.5
RT (go errors) 303.6 342.3 319.8 309.6
Percentage of go errors 12.0 9.2 9.4 8.9
Posterror slowing 13.8 15.8 11.6 12.4
Post-noninhibition slowing 8.0 2.7 18.0 19.1
Percentage of corrected errors 80.2 88.4 89.7 86.7
Stop-signal delay 103.2 134.2 114.2 116.6
SSRT 271.5 275.6 263.4 249.7
Percentage of artifact rejections 20.2 15.7 13.6 15.4
Included go errors 146.5 123.8 130.6 124.8
Included stop errors 129.9 137.3 137.9 132.9
RT, Reaction time of correct responses in milliseconds; Percentage of go errors, percentage of error trials of all go trials; Percentage of corrected errors, the
number of corrected go errors relative to all go errors; Percentage of artifact rejection, the average percentage of rejected EEG epochs caused by artifacts;
Included go and stop errors, the average number of included error trials after artifact rejection; M, male; F, female.
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fication and melting analysis were performed on a Light Cycler480
automate instrument (Roche). For PCR amplification the LightCy-
cler480 genotyping master (Roche) was used in a 384-well format
with 10 l reaction volumes. Cycling conditions with touchdown
annealing temperatures from 65°C to 55°C over the first 10 cycles
were as follows: 10 min, 95°C, 45 cycles with 20 s annealing temper-
ature; 20 s, 72°C; and 20 s, 95°C followed by a high-resolution melting
curve from 50°C to 85°C with continuous fluorescence acquisition.
Genotypes of participants selected for ERP were controlled in an in-
dependent second DNA sample by direct sequencing using the ABI
PRISM BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosys-
tems, Foster City, CA). Sequencing products were resolved on an ABI
3100 automated Sequencer (Applied Biosystems) and analyzed using the
Staden Package (Bonfield et al., 1995).
Paradigm. We applied a modified variant of the Eriksen flanker task
(Eriksen and Eriksen, 1974) that required the participants to respond to
the central arrow in an array of five arrows (with the right hand after a
right-directed arrow and vice versa). The four surrounding arrows were
either compatible or incompatible to the central arrow, favoring perfor-
mance errors. We presented 33.3% of compatible and 50% of incompat-
ible trials. In the remaining 16.6% of trials, we included no-go trials,
following a variant of the stop-signal paradigm (Band et al., 2003). In
these trials, the central green arrow changed to red after a variable delay,
indicating participants to inhibit the response in these trials. The delay
was adapted to participants behavior by means of a staircase tracking
algorithm (Band and van Boxtel, 1999) as follows. The stop-signal delay
was set to 140 ms initially. After a successful inhibition the stop-signal
delay was increased by 10 ms (making the inhibition harder), after a
failure in inhibition the stop-signal delay was reduced by 10 ms (making
the inhibition easier). This procedure was applied to yield an inhibition
rate of 50%. We computed the stop-signal reaction time (Band et al.,
2003) by subtracting the participant’s mean stop-signal delay from the
median reaction time of correct go responses. Each stimulus array was
presented in the middle of the screen. Stimulus duration was 300ms and
the stimulus onset asynchrony was fixed to 900ms. Participants received
20 training trials to get acquainted to the task. They were encouraged to
correct their errors in the go trials as fast as possible. The experiment was
divided in eight blocks, each comprising 240 trials, resulting in a total
amount of 1920 trials.
ERPs.The electroencephalogram (EEG)was recorded from29 tin elec-
trodes mounted in an elastic cap (electrode positions: Fp1/2, F3/4, C3/4,
P3/4, O1/2, F7/8, T3/4, T5/6, FC1/2, FC5/6, CP1/2, CP5/6, PO1/2, Fz, Cz,
Pz) with reference electrodes placed on the right and left mastoids. Dur-
ing recording, all scalp electrodes were referenced against an average
reference and off-line re-referenced against the algebraic mean of the
activity at the two mastoid electrodes. Electrode impedances were kept
below 5 k. Vertical eye movements and blinks were monitored by an
electrode placed below the right eye. EEG and EOG were recorded con-
tinuously and digitized with a sampling rate of 250 Hz (bandpass from
0.01–70 Hz). After individualized rejection of eye and muscle artifacts,
stimulus- and response-locked averages were obtained for the different
conditions (100–924 ms for stimulus-locked averages and400–600
ms for response-locked ERPs). In the stimulus-locked ERPs, the 100 ms
preceding the stimulus was considered as baseline; in the response-
locked ERPs, baseline was defined as the 50 ms before the button press.
Only reaction time responses that were produced between 120 and 750
ms after the stimulus were considered in the behavioral and ERP analy-
ses. All artifact-free error trials were included regardless of a subsequent
corrective response.
For statistical analyses, mean amplitudes (unless otherwise stated)
were subjected to repeated measures ANOVA with the between-
subject factors COMT (Met vs Val) and DRD4 (T vs C) and the
within-subject factors condition and electrode position, dependent
on the particular component (as stated below). For all statistical ef-
fects involving more than one degree of freedom in the numerator,
the Huynh-Feldt correction was applied to correct for possible viola-
tions of the sphericity assumption (Huynh and Feldt, 1976). The
corrected probabilities together with the corresponding -values are
reported. Because our approach to genotype effects on the neuro-
physiological correlates of performance monitoring was hypotheses-
driven (see Introduction), and because we restricted our analysis to
previously described ERP components, we did not apply a Bonferroni
correction for multiple comparisons.
Results
Behavioral results
Participants reacted faster in compatible (mean reaction time
373 33ms SD) than in incompatible (399 36) go trials, being
in line with usual findings in flanker tasks (F(1,36) 121.23, p
0.001). The mean percentage of errors was 9.9% (5.9), being
higher in incompatible trials (12.3%) than in compatible trials
(6.2%; F(1,36) 215.57, p 0.001), and error responses were as
expected faster than correct responses (errors, 319 37 ms; cor-
rect responses, 390 ms 35.2; F(1,36) 311.82, p 0.001). The
meanpercentage of inhibited no-go trials was 48.8% (2.6), with
an average stop-signal delay of 117 ms (39). Participants cor-
rected on average 86.3% (22.9) of their errors with a response
time of the corrections of 204 ms (relative to the first response;
59). Behavioral data of the four groups are depicted in Table 1.
Participants with the C/C-Val/Val genotype were slower in their
overall reaction time in both their correct and their erroneous
responses (COMT by DRD4 interaction, F(1,36)  5.35, p 
0.027).
In agreement with previous findings in the flanker task, we
observed slower responses in trials after errors compared with
trials after correct responses (posterror slowing, 13.4 16.4 ms)
(Rabbitt, 1966). The same result was observed for the trials that
followed failed inhibitions (post-noninhibition slowing, 10.6 
18.9ms). Interestingly, participants with theDRD4T/T genotype
reduced their speed after failed inhibitions significantly more
than individuals with the C/C genotype (main effect DRD4,
F(1,36)  8.46, p  0.006; T, 18.5 ms; C, 2.6 ms). Moreover,
carriers of the T allele had a shorter stop-signal reaction time
(SSRT) (Band et al., 2003), reflecting faster inhibitory processes
in these participants (F(1,36)  4.85, p  0.034; T, 256.6 ms; C,
273.6 ms).
Event-related potentials
The percentage of EEG epochs that were rejected because of arti-
facts was 16.2% (7.1) with no difference between the groups
(main effects and interaction of COMT andDRD4, p 0.1). The
mean number of errors in go trials (reactions with the wrong
hand) included in the average after artifact rejection was 131.4
(80.6), whereas themean number of false alarms in no-go trials
was 134.5 (12.9). Both did not differ between the groups (all
main effects and interactions of COMT andDRD4, p 0.1). The
percentage of artifact rejections and included errors in the four
groups are reported in Table 1.
ERPs: response-locked data
Both errors in go trials (in the following referred to as choice
errors) and in no-go trials (referred to as stop errors) led to an
increased negativity peaking shortly after the error, resembling
the well known ERN component with its characteristic fronto-
central distribution (Falkenstein et al., 1990; Gehring et al., 1993)
(Figs. 1, 2). The negativity after choice errors peaked at 60 ms
after the response, whereas the negativity after stop errors peaked
slightly later at90 ms after the response. Results for both con-
ditions will be reported separately.
Go trials
The ERN for choice errors was clearly present but differentially
pronounced in the four groups (Fig. 1). First visual inspection
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suggested a larger ERN in Val and T ho-
mozygous participants compared withMet
and C homozygotes. To investigate these
genotype effects we subjected the mean
amplitude at Fz and Cz between 0 and 100
ms for correct go trials and choice errors to
a repeated measures ANOVA with the
between-subject factors COMT and DRD4
and the within-subject factors condition
(correct responses vs choice errors) and
electrode (Fz and Cz).We performed these
analyses with bandpass-filtered data, in
which the ERN is best detectable (bandpass
2–8 Hz).
The differences in the choice ERN be-
tween the groups were reflected by a signif-
icant interaction of condition by DRD4
(F(1,36)  5.29, p  0.026) because of a
higher ERN in T-homozygous (condition,
F(1,19) 38.96, p 0.001) compared with
C-homozygous participants (condition,
F(1,19)  32.97, p  0.001) (Fig. 1A,B, for
topography). We performed an additional
through-to-peak measurement at Fz and
Cz to confirm this genotype effect on the
ERN.We defined the ERNpeak as themost
negative peak in the time-window between
0 and 130 ms and computed the amplitude
difference to the preceding positive peak.
The trough-to-peak amplitude at Fz and
Cz for the four groups is depicted in Figure
1C. The corresponding ANOVA applied to
this amplitude difference with the
between-subject factors COMT and DRD4
and the between-subject factor electrode
(Fz and Cz) confirmed again a main effect
of DRD4 (F(1,36) 4.61, p 0.039).
Stop trials
Similarly to choice errors, an enhanced
negativity peaking shortly after the false
alarm responses in stop trials could be de-
tected in the four groups. Visual inspection
of the corresponding average waveforms
suggested a larger negativity in T and Val
participants comparedwithC andMet par-
ticipants (Fig. 2). As before we subjected
themean amplitude at Fz andCz between 0
and 130 ms for correct go trials and stop
errors to a repeatedmeasuresANOVAwith
the between-subject factors COMT and
DRD4 and the within-subject factors con-
dition (correct go responses vs stop errors)
and electrode (Fz and Cz). We again used
bandpass-filtered data for these analyses
(bandpass 2–8 Hz).
Comparing stop errors with correct go
responses revealed a significant effect for
DRD4 (condition by DRD4, F(1,36) 6.75,
p 0.013) and amarginal significant effect
for COMT (condition by COMT, F(1,36)
3.24, p  0.080). The DRD4 effect was
caused by a higher ERN in the
Figure 2. A, Grand averages of response-locked ERPs at midline electrodes in participants homozygous for the C and T
allele (DRD4 –521). Depicted are ERPs for correct trials (dashed lines), stop-error trials (solid thick lines), and the differ-
ence waveforms (solid thin lines). For illustration the data were bandpass filtered (bandpass filter, 2– 8 Hz). B, Isovoltage
maps of the difference waveform for the time window 0 –130ms in the homozygotes for the C and T allele (maximum and
minimum values in microvolts are5.5 and 0.5). C, Mean trough-to-peak amplitudes at Fz and Cz for the four different
groups with the respective SEs.
Figure 1. A, Grand averages of response-locked event-related potentials at midline electrodes in individuals homozy-
gous for the C and T allele (DRD4 –521). Depicted are ERPs for correct trials (dashed lines), error trials (solid thick lines) and
the difference waveforms (solid thin lines). For illustration the data were bandpass filtered (bandpass 2– 8 Hz). B,
Isovoltage maps of the difference waveform for the time window 0 –100 ms in homozygotes for the C and T allele
(maximum andminimum values in microvolts are4.5 and 0.5). C, Mean trough-to-peak amplitudes at Fz and Cz for the
four different groups with the respective SEs.
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T-homozygous (F(1,19)  58.77, p  0.001) compared with
C-homozygous participants (F(1,19)  49.07, p  0.001) (Fig.
2A,B, for topography). In parallel to the analyses of the choice
ERN, we performed additionally a trough-to-peak amplitude at
Fz and Cz to confirm these results for the stop negativity. The
trough-to-peak amplitude at Fz and Cz in the four groups is
shown in Figure 2C.We again found a significant effect forDRD4
(F(1,36)  4.85, p  0.034) and a tendency for COMT (F(1,36) 
3.50, p 0.069) (Fig. 2C).b
In summary, the results of the response-locked data
showed a main effect of the DRD4 polymorphism on both the
choice ERN and the stop-error negativity, with a tendency for
an additional COMT effect on the stop-error negativity at
least. It has to be noted, that the genotype effects were only
small and the significance level not corrected for multiple
comparisons. Future studies will be needed to replicate the
current findings.
ERPs: stimulus-locked data
Incompatibility effects
Stimulus-locked ERPs in both compatible and incompatible
go trials were characterized by a typical visual N1-P2 complex,
followed by a frontocentral negativity peaking at 300 ms
(N2), that was superimposed on an extended positivity with a
posterior maximum (P300). As expected, the N2 was en-
hanced for incompatible compared with compatible trials.
Moreover, the peak of the P300 component was delayed in
incompatible trials (Fig. 3).
To probe the N2 incompatibility effect for group differ-
ences, we subjected the mean amplitude between 250 and 350
ms at midline electrodes to a repeated measures ANOVA with
the between-subjects factors COMT and DRD4 and the
within-subject factors condition (compatible vs incompati-
ble) and electrode (levels: Fz, Cz, and Pz). These analyses were
performed with unfiltered data. The incompatibility effect on
the N2 amplitude was confirmed by the interaction of condi-
tion by electrode (F(1,36)  6.86, p  0.003). Yet, neither an
interaction of COMT or DRD4 and condition nor main effects
of genotypes on the N2 incompatibility effect were detected
(all p values  0.1), suggesting that both polymorphisms had
no effect on this neurophysiological marker of conflict
monitoring.
To tap into possible genotype effects on the P300 latency, we
subjected the P300 peak latency at Pz (most positive peak be-
tween 300 and 600 ms) to a repeated measures ANOVA with the
same factors as before (except electrode). The finding of a delayed
P300 in incompatible compared with compatible trials was re-
flected by the significantmain effect of condition (F(1,36) 18.98,
p 0.001). No interaction of COMT and DRD4 with condition
was detected (all p values  0.1). Thus, both incompatibility
effects (N2 amplitude and P3 latency) showed no modulation by
the dopaminergic polymorphisms. There was a slight tendency
for a generally enhanced P300 amplitude (defined as the mean
amplitude between 300 and 600 ms) in the T/T-group, indicated
by amarginal significantmain effect of DRD4 (F(1,36) 3.33, p
0.076).
Inhibitory effects
ERPs time-locked to the stop signal showed a sharp central neg-
ativity at200 ms (N2)c followed by a broad posterior positivity
(Fig. 4). This negativity was clearly detectable in both inhibited
and noninhibited trials. In trials of failed inhibitions a second
negativity followed, peaking at 300 ms, reflecting the stop-
error-related negativity which was previously analyzed in the sec-
tion on response-locked ERPs. This enhanced negativity for
failed inhibitions was overlapping with the previously reported
stop-related P3a, that was shown to be larger for successful inhi-
bitions (Liotti et al., 2005).
When directly contrasting trials of successful inhibitions in
bThe analyses for the error-related negativity were additionally performed in unfiltered data. Both the DRD4 effect
on the choice ERN (mean amplitude at Fz, 0–100ms) and stop negativity (mean amplitude at Fz, 0–130ms) were
confirmed (both p 0.05).
cThe inhibition-related negativity in stop trials as well as the incompatibility-related negativity discussed in the
previous section are referred to in the ERP literature as N2, although they represent separate phenomena. We will
therefore use the labels stop N2 and incompatibility N2 in the remainder of the study to distinguish the two effects.
Figure 3. Grand averages of stimulus-locked ERPs at Cz in the four groups. Depicted are
compatible (solid thick line) and incompatible trials (dashed thick line) and the difference
waveform (solid thin line). For illustration the data were low-pass filtered (low-pass filter, 12
Hz). Shown is the isovoltagemapof the differencewaveform for the timewindow250–350ms
(N2) in the complete sample (maximum andminimum values inmicrovolts are1.0 and 0.5).
Figure 4. Grand averages of stop stimulus-locked ERPs at selected electrodes for the com-
plete sample. Depicted are inhibited (dashed lines) and noninhibited trials (solid lines). Again,
the data were low-pass filtered for illustration (12 Hz) and N2 and P3a are highlighted.
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the different groups, an increased amplitude of the stop N2 and
an enhanced positivity was evident in the Val participants com-
pared withMet participants (Fig. 5; note that for illustration pur-
poses, a bandpass filter of 2–12 Hz was used in Fig. 5B). We
defined the stop N2 as the peak-to-peak amplitude (difference
between the negative peak 180–250 ms and the preceding posi-
tive peak; determined in low-pass filtered data, low-pass 12 Hz)
to avoid a confound with differences in the underlying positivity.
The peak-to-peak amplitude was measured at Fz, where the stop
N2 and the group differences were largest and is depicted for the
four groups in Figure 5D (Fig. 5C, for scalp topography). The
larger stop N2 in the Val group was confirmed by the main effect
of COMT (F(1,36) 5.59, p 0.024; Val,7.37 V;Met,4.96
V). We observed no main effect of or interaction with DRD4
( p 0.1) (Fig. 5D).
After the stop N2, an extended positivity (P3a) could be de-
tected (Fig. 5A,C, for scalp topography), peaking at 300–350
ms andmaximally pronounced at central electrodes (Liotti et al.,
2005). The inhibition-related P3a was similar to the stop N2
higher in Val than in Met carriers. This was corroborated by a
mean amplitudemeasurement atmidline electrodes between 300
and 350 ms (main effect COMT: F(1,36)  4.48, p  0.041). The
mean amplitude in the four groups is depicted in Figure 5E.
Discussion
The present study demonstrates the impact of two polymor-
phisms in the dopaminergic system on neurophysiological
markers of executive functions. Genetic variability in the
DRD4–521 polymorphism predicted interindividual differ-
ences in error-related prefrontal activity and in behavioral
post-error adjustments. Additionally, a genetically driven
lower level of COMT was associated with reduced inhibition-
related frontal activity.
Error monitoring
DRD4–521 T allele-homozygous participants showed increased
frontocentral negativities after both choice and stop errors com-
pared with C allele carriers. Moreover, a
tendency for an additional COMT effect
was seen with a larger negativity in Val-
compared with Met-homozygous partici-
pants for stop errors. These results hint at
specific effects on action monitoring pro-
cesses reflected in the error negativity. On
a behavioral level, T-homozygous partici-
pants showed greater posterror adjust-
ments in particular after failed inhibitions.
Different models have been suggested
regarding the ERN, relating it to, for exam-
ple, error detection (Gehring et al., 1993)
or conflict monitoring (Yeung et al.,
2004). Holroyd and Coles (2002) previ-
ously proposed a direct link of the ERN to
activity in the mesencephalic dopaminer-
gic system. Their reinforcement-learning
model assumes a response-monitoring
system in the basal ganglia, producing pos-
itive and negative prediction error signals,
that are coded as phasic increases or de-
creases of activity of mesencephalic dopa-
minergic neurons. The ERN emerges,
when phasic decreases in the activity of
mesencephalic dopaminergic neurons dis-
inhibit the apical dendrites in motor neu-
rons in the ACC. Finally the ACC and other areas as the amygdala
or hippocampus, which receive input frommesencephalic dopa-
minergic neurons, project back to the basal ganglia, where the
information is used to improve prediction of the monitoring
system.
Different mechanisms are possible how D4 receptor avail-
ability and COMT level might affect functioning in this loop.
The dopamine D4 receptor is expressed mainly in the prefron-
tal cortex (including ACC), in the amygdala and in the hip-
pocampus, making a modulatory impact in these areas very
likely (Oak et al., 2000). Moreover, studies with D4 receptor
knock-out mice suggest that D4 receptor expression rate leads
to compensatory changes in mesencephalic dopamine pro-
duction, resulting in different tonic dopamine levels in partic-
ipants homozygous for the T andC allele in DRD4 (Rubinstein
et al., 1997). Thus, the DRD4 polymorphism in question
might also directly impact prediction error signaling in the
basal ganglia and thereby the ERN. Interestingly, evidence
exists for an association with schizophrenia and ADHD for
DRD4–521 alleles, supposedly stemming from altered pre-
frontal activity (Okuyama et al., 1999; Mill et al., 2003; Xing et
al., 2003). Additionally, several studies demonstrated dis-
turbed performance monitoring mechanisms reflected in a
reduced ERN in schizophrenic and ADHD patients (Kopp and
Rist, 1999; Alain et al., 2002; Mathalon et al., 2002; Liotti et al.,
2005). Although the direct impact of the SNP-521 on D4 re-
ceptor availability remains controversial (Okuyama et al.,
1999; Kereszturi et al., 2006), the present study provides direct
evidence for differences in specific prefrontal functions driven
by this polymorphism, that might contribute to a higher risk
for psychiatric disorders as schizophrenia or ADHD.
COMT is the main mechanism for prefrontal dopamine
turnover because of a sparse expression of the dopamine
transporter (Matsumoto et al., 2003; Chen et al., 2004). In
addition to the direct impact COMT might thus have on pre-
frontal functioning, different mechanisms have been pro-
Figure 5. A, Grand averages of stop stimulus-locked ERPs at midline electrodes in the Val (dashed lines) andMet groups
(solid lines) for successfully inhibited trials. The P3a is indicated with an arrow. B, For illustration of the N2 effect, ERPs in
inhibited trials are shown for the two groups at the Fz electrode with a bandpass filter of 2–12 Hz. C, Depicted are the
isovoltage maps of the amplitude difference between Val/Val andMet/Met for the stop N2 (200 –220 ms; left) and the P3a
(300 –350 ms; right). As the groups differed in the preceding positivity of the N2, we show for illustration the amplitude
difference relative to the baseline from 100 to 200ms. Maximum andminimum values are for the N2 are1.2 and 0.2V,
and for the P3a are1.5 and 5.5V. D, Mean peak-to-peak amplitudes for the N2 at Fz for the four different groups in
inhibited trials (with their respective SEs). E, Mean amplitudes for the P3a in the four different groups in inhibited trials
(300 –350 ms) with their respective SE.
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posed for a relationship between COMT activity and dopa-
mine release in the basal ganglia: extrasynaptic COMT in the
basal ganglia might directly influence local tonic dopaminer-
gic activity (Huotari et al., 2002) or, alternatively, prefrontal
COMT level might drive striatal dopamine levels via a regula-
tion of glutamatergic projections from PFC to the basal gan-
glia (Bilder et al., 2004; Meyer-Lindenberg et al., 2006). More
specifically, lower COMT level will increase firing of pyrami-
dal neurons in the PFC and increase corticostriatal glutamate
transmission, resulting finally in increased glutamate-
stimulated tonic dopamine release in the striatum and sup-
pression of phasic dopamine release (Bilder et al., 2004). The
lower COMT level in individuals homozygous for the Met
allele is thus supposed to be associated with an increased tonic
dopamine release and reduced phasic dopamine responses in
the basal ganglia (Yacubian et al., 2007), which leads to the
prediction of a reduced ERN which is what we found.
Conflict monitoring
Regarding the incompatibility effects in the stimulus-locked
data, we observed the typical enhanced negativity for incom-
patible compared with compatible trials and a delayed P300.
However, no differentiation between the groups could be de-
tected in these markers of conflict monitoring. This is some-
how surprising, because Fossella et al. (2002) reported a
COMT polymorphism impact on the incompatibility effect
even on the behavioral level, with the Met participants show-
ing a tendency for a higher distractability and thereby higher
incompatibility effect. Moreover, a previous functional mag-
netic resonance imaging study reported an effect for COMT
on ACC activity during a similar, albeit more demanding
flanker task (Blasi et al., 2005). Blasi et al. (2005) demon-
strated a linear relationship of ACC activity driven by atten-
tional control with the number of Val alleles, with the highest
ACC activity in homozygous Val participants. Because Val
participants at the same time exhibited the poorest perfor-
mance, the authors conclude a less efficient prefrontal pro-
cessing in these participants. However, this effect was most
prominent at the highest level of attentional control, suggest-
ing that the null effects in the present study might be caused by
an overall lower demand for conflict monitoring. It should be
pointed out though, that only the participants homozygous
for the C/C and Val/Val alleles showed unspecific perfor-
mance deficits in the present study (overall slower reaction
times), but no increased error rates could be detected in Val/
Val homozygotes as in the study of Blasi et al. (2005). In fact,
there was even a tendency for higher error rates in Met/Met
participants, although this was not significant.
Response inhibition
Stimulus-locked data for the stop signal showed a typical
inhibition-related stop N2, that was observable in both success-
fully inhibited trials and failed inhibitions. This was followed by a
positive deflection (P3), that was at frontal sites more pro-
nounced for successfully inhibited trials.
The stop N2 in stop signal tasks has been suggested to
reflect monitoring processes in the prefrontal cortex, related
to a “red flag” signal triggering the inhibitory process (Kok,
1986). We observed an effect of the COMT polymorphism on
the stop N2, such that Val participants revealed a greater am-
plitude compared with Met carriers. This goes in line with
previous evidence, pointing at interindividual differences in
prefrontal processes driven by genetically determined dopa-
minergic variability (Egan et al., 2001; Blasi et al., 2005; Schott
et al., 2006). Interestingly, similar group differences in the
stop N2 have been observed comparing boys with ADHD and
a healthy control group (Pliszka et al., 2000). The N2 was
shown to be greatly reduced in ADHD children, pointing at a
neurophysiological correlate of their impaired inhibitory con-
trol. Given the previously reported link between the COMT
polymorphism and ADHD (Bellgrove et al., 2005b), the
present data thus suggest a possible underlying neural mech-
anism for this relationship. Because the DRD4 polymorphism
has been also associated with ADHD, it remains an open ques-
tion why we did not observe any effects related to DRD4.
Additionally, participants homozygous for the Val allele
(COMT) presented an enhanced inhibition-related central
positivity (also referred to as P3a) compared with Met-
homozygote participants (Kok et al., 2004; Bekker et al., 2005;
Liotti et al., 2005). As the time needed to successfully inhibit a
response, indicated by the SSRT, finishes clearly before the P3,
this component cannot reflect the inhibition process per se. It
has rather been related to a later stage of the inhibitory pro-
cess, indexing the monitoring of its successful implementation
instigated by the anterior cingulate or pre-SMA (Liotti et al.,
2005). Similarly to the stop N2, the P3a has been shown to be
diminished in ADHD and related to behavioral indices of re-
sponse inhibition (Liotti et al., 2005). Interestingly, at least in
the homozygotes for the Val allele and the T allele, the in-
creased P3a was associated with a shorter SSRT (i.e., better
task performance). This is in contrast to previous studies re-
lated to working memory and attentional control (Egan et al.,
2001; Blasi et al., 2005), demonstrating genetically driven in-
creased prefrontal activity associated with impaired task
performance.
Conclusions
The present study is the first to provide direct evidence for the
impact of two dopaminergic polymorphisms on neurophysi-
ological correlates of performance monitoring by means of
ERPs (for data on serotonin-related genetic influence on the
ERN, see Fallgatter et al., 2004). The results suggest a distinct
effect of the DRD4 SNP-521 on error monitoring, evident in
the group differences in the choice ERN and the stop-related
ERN. Moreover, increased post-error slowing in the partici-
pants homozygous for the T allele (DRD4) hint at behavioral
costs of this elevated performance monitoring. However, the
COMT Val108/158Met polymorphism affected inhibition-
related neurophysiological markers, with the participants car-
rying the Val allele revealing enhanced prefrontal processing.
Interestingly, especially for the “extreme” group of partici-
pants homozygous for T allele in DRD4 and the Val allele in
COMT, the present study demonstrates increased prefrontal
functioning related to performance monitoring processes that
were associated with both behavioral costs, evident in the in-
creased post-error slowing, and behavioral benefits, observ-
able in the shorter SSRT. This parallels previous observations
suggesting distinct behavioral costs emanating from elevated
or diminished dopaminergic functioning (Cohen et al., 2002;
Bilder et al., 2004; Seamans and Yang, 2004).
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